<qa>  What is the purpose of this study?The purpose of this study is to evaluate the safety and tolerability, identify the Maximum Tolerated Dose MTD or the Minimum Efficacious Dose MED and designate a dose level for Phase 2. Also characterize the immunogenicity, pharmacokinetic profile, and biomarker serum levels of ALT-803 in treated patients. 